Financials

  • Market Capitalization 153.7 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.59
Fiyat/satışlar oranı
34.34

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3735
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.64 USD0.00%+3.23%-33.33%+55.15%155.81 M USD
3740
TNYA
Tenaya Therapeutics, Inc. - Common Stock
0.69 USD-1.43%-1.43%-6.76%-38.39%154.72 M USD
3748
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.14 USD-1.72%-8.06%-13.64%-40.00%151.90 M USD
3751
EQ
Equillium, Inc. - Common Stock
2.39 USD-2.45%+4.37%+9.13%+43.11%151.55 M USD

Haberler